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SUMMARY 
 
Alpha-synuclein is a highly conserved, ubiquitously expressed protein in the 
vertebrate brain. It was discovered in 1988 and was purported to play a role in song 
learning, implicating a role in synaptic plasticity. Alpha-synuclein came under 
increased scrutiny shortly thereafter as the non-amyloid component isolated from 
plaques from Alzheimer’s disease brains. Following this discovery, alpha-synuclein 
was further characterised as the main component in numerous additional inclusion 
bodies found in several neurodegenerative disease leading to speculation that alpha-
synuclein was involved in disease pathogenesis.  
 
Two decades later little is known about the normal function of alpha-synuclein in 
neuronal cells, however numerous studies have determined alpha-synuclein is able to 
form fibrils and aggregates, and that these may provide the neurotoxic mechanism by 
which alpha-synuclein exerts its effect in disease states. Other studies have 
demonstrated the formation of fibrillar aggregates of alpha-synuclein is a 
neuroprotective mechanism. The issues of the cellular role and neurotoxicity of 
alpha-synuclein remain contentious. This thesis provides evidence indicating a 
developmentally regulated role for alpha-synuclein in neurons and oligodendrocytes, 
as well as roles in neuroprotection, plasticity and regeneration. This thesis has 
demonstrated synuclein isoforms have a distinct pattern of localisation during 
neuronal development, indicating alpha-, beta- and gamma-synuclein also have 
distinct functionality within neuronal development, and that these functions may 
alter as neurons develop.  
 
Alpha-synuclein immunoreactive neuritic abnormalities were shown to be caused by 
physical insult to the axon, leading to the accumulation of alpha-synuclein protein in 
neuronal processes, and were associated with neurofilament pathology mirroring that 
seen in some disease states containing aggregated forms of alpha-synuclein. It was 
demonstrated alpha-synuclein is involved in regenerative sprouting following axonal 
injury, further implying a role for alpha-synuclein in aspects of growth cone 
development and/or maturation as well as neuronal plasticity.  
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Additionally, synuclein isoforms were shown to have a distinct pattern of localisation 
during oligodendroglial development, indicating alpha-, beta- and gamma-synuclein 
also have distinct functionality within oligodendrocytes, and these functions may 
alter throughout development. In this case exogenous alpha-synuclein was 
demonstrated to be taken up by oligodendrocytes, and incorporated into cytoplasmic 
inclusions, along with endogenous alpha-synuclein, implying a mechanism by which 
alpha-synuclein interacts with oligodendrocytes in disease states leading to the 
formation of glial cytoplasmic inclusions. Finally, and importantly this thesis 
demonstrated an increase in alpha-synuclein in response to stressful stimuli is 
beneficial to neuronal survival as part of a normal neuronal response in a 
subpopulation of neurons. This finding is somewhat contentious as many of the 
studies into the role and mechanism of alpha-synuclein in disease states support its 
neurotoxicity, yet this thesis contradicts this, providing evidence for a 
neuroprotective affect of alpha-synuclein. 
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ABBREVIATIONS 
 
aa   amino acid 
AD   Alzheimer’s disease 
ALS   amyotrophic lateral sclerosis 
ATP   adenosine triphosphate 
A53T   missense mutant alpha-synuclein 
A30P   missense mutant alpha-synuclein 
BAD   Bcl-associated death promoter 
CNS   central nervous system 
CSF   cerebrospinal fluid 
CSP-alpha  cysteine-string protein alpha 
DA   dopamine 
DAI   diffuse axonal injury 
DAT   dopamine transporter 
DHR-123  dihyrdrorhodamine – 1,2,3 
DIV   days in vitro 
DLB   dementia with Lewy bodies 
DLBD   diffuse Lewy body dementia 
DMEM  Dulbecco’s Modified Eagle’s Medium 
EDTA   ethylenediamine tetra acetic acid  
ER   endoplasmic reticulum 
ERK   extracellular signal regulated kinase 
E46K   missense mutant alpha-synuclein 
GCI   glial cytoplasmic inclusion 
GNI   glial nuclear inclusion 
GRK   G protein coupled receptor kinase 
HBSS   Hank’s Balance Salt Solution 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulphonic  
acid 
IR   immunoreactivity 
kDa   kilo dalton 
LB   Lewy body 
LBVAD  Lewy body variant of Alzheimer’s disease 
LN   Lewy neurite 
LRRK2  Leucine-rich repeat kinase 2 
MAO   mono-amine oxidase 
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MAP   microtubule-associated protein 
MPTP   1-methyl-1-phenyl-1,2,3,6-tetrahydropyridine 
mRNA   messenger ribonucleic acid 
MSA   multiple systems atrophy 
NA   noradrenaline 
NAC   non-amyloid component 
NACP   non-amyloid component precursor protein 
NCI   neuronal cytoplasmic inclusion 
NFH   neurofilament heavy chain 
NFL   neurofilament light chain 
NFM   neurofilament medium chain 
NFT   neurofibrillary tangle 
NNI   neuronal nuclear inclusion 
OE   olfactory epithelium 
ORN   olfactory receptor neuron 
PARK1  alpha-synuclein gene 
PBS   phosphate buffered saline 
PD   Parkinson’s disease 
PFA   paraformaldehyde 
PINK1 phosphatase and tensin (PTEN) homologue - 
induced putative kinase 1 
PKC   protein kinase C 
PM   plasma membrane 
PNP-14  phosphoneuroprotein 14 kDa 
RNA   ribonucleic acid 
ROS   reactive oxygen species 
SEM   standard error of the mean 
SN   substantia nigra 
SNCA   alpha-synuclein gene 
SNpc   Substantia nigra pars compacta 
SNpr   Substantia nigra pars reticulata 
SOD   superoxide dismutase 
TH   Tyrosine hydroxylase 
WT   wild type 
 
